Treatment IND

Results: 67



#Item
1Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmace

Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmace

Add to Reading List

Source URL: www.morphochem.de

Language: English - Date: 2016-07-05 04:16:59
    2Microsoft Worddoc

    Microsoft Worddoc

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    3Special circumstances  regarding expanded  access at Stanford  In most circumstances, medical    research using  investigational  drugs, biologics and devices   

    Special circumstances  regarding expanded  access at Stanford  In most circumstances, medical    research using  investigational  drugs, biologics and devices   

    Add to Reading List

    Source URL: humansubjects.stanford.edu

    Language: English - Date: 2016-04-12 01:21:50
    4Expanded Access to Investigational Drugs and Biologics _______________________________When All Else Fails__________________________

    Expanded Access to Investigational Drugs and Biologics _______________________________When All Else Fails__________________________

    Add to Reading List

    Source URL: www.reaganudall.org

    Language: English - Date: 2016-05-24 12:16:34
    5Emory IRB Guidance for Investigators  Guidance for the IRB Submission of an Expanded Access IND (Treatment or Emergency use) of an Unapproved Drug The guidance below is for use of an unapproved drug to treat a patient or

    Emory IRB Guidance for Investigators Guidance for the IRB Submission of an Expanded Access IND (Treatment or Emergency use) of an Unapproved Drug The guidance below is for use of an unapproved drug to treat a patient or

    Add to Reading List

    Source URL: www.irb.emory.edu

    Language: English - Date: 2015-02-04 16:48:22
    6h e a lt h p o l ic y b r i e f  1 w w w. h e a lt h a f fa i r s .o r g

    h e a lt h p o l ic y b r i e f 1 w w w. h e a lt h a f fa i r s .o r g

    Add to Reading List

    Source URL: healthaffairs.org

    Language: English - Date: 2015-03-04 09:44:55
    7h e a lt h p o l ic y b r i e f  1 w w w. h e a lt h a f fa i r s .o r g

    h e a lt h p o l ic y b r i e f 1 w w w. h e a lt h a f fa i r s .o r g

    Add to Reading List

    Source URL: healthaffairs.org

    Language: English - Date: 2015-04-09 08:15:32
    8Guidance for Industry IND Exemptions for Studies of Lawfully Marketed Drug or Biological Products for the Treatment of Cancer  U.S. Department of Health and Human Services

    Guidance for Industry IND Exemptions for Studies of Lawfully Marketed Drug or Biological Products for the Treatment of Cancer U.S. Department of Health and Human Services

    Add to Reading List

    Source URL: rsdfoundation.org

    Language: English - Date: 2009-07-14 14:09:22
    9

    PDF Document

    Add to Reading List

    Source URL: www.fda.gov.

    Language: English
    10

    PDF Document

    Add to Reading List

    Source URL: www.fda.gov.

    Language: English